46
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Analysis of HLA Class I and Class II Gene Polymorphisms in Japanese Patients with Human T-Cell Lymphotropic Virus Type 1-Associated Uveitis

, , , , &
Pages 199-204 | Accepted 29 Nov 2003, Published online: 08 Jul 2009

REFERENCES

  • Poiesz B J, Ruscetti F W, Gazdar A F, Bunn P A, Minna J D, Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–7419, [PUBMED], [INFOTRIEVE]
  • Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481–492, [PUBMED], [INFOTRIEVE]
  • Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1(8488)1031–1032, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gessain A, Barin F, Vernant J C, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985; 2(8452)407–410, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ohba N, Matsumoto M, Sameshima M, Kabayama Y, Nakao K, Unoki K, Uehara F, Kawano K, Maruyama I, Osame M. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 1989; 33: 1–12, [PUBMED], [INFOTRIEVE], [CSA]
  • Nakao K, Matsumoto M, Ohba N. Seroprevalence of antibodies to HTLV-I in patients with ocular disorders. Br J Ophthalmol 1991; 75: 76–78, [PUBMED], [INFOTRIEVE]
  • Ohba N, Nakao K, Isashiki Y, Osame M, Sonoda S, Yashiki S, Yamaguchi K, Tajima K. A multicenter case-control study of HTLV-I associated uveitis. Study Group for HTLV-I Associated Ocular Diseases. Jpn J Ophthalmol 1994; 38: 162–167, [PUBMED], [INFOTRIEVE], [CSA]
  • Ohba N, Nakao K, Isashiki Y, Kaminagayoshi T, Sonoda S, Yashiki S, Osame M. Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study. Study Group for HTLV-I Associated Ocular Diseases. Jpn J Ophthalmol 1994; 38: 168–174, [PUBMED], [INFOTRIEVE], [CSA]
  • Nakao K, Ohba N, Nakagawa M, Osame M. Clinical course of HTLV-I-associated uveitis. Jpn J Ophthalmol 1999; 43: 404–409, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Sagawa K, Mochizuki M, Masuoka K, Katagiri K, Katayama T, Maeda T, Tanimoto A, Sugita S, Watanabe T, Itoh K. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest. 1995; 95: 852–858, [PUBMED], [INFOTRIEVE], [CSA]
  • Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Invest Ophthalmol Vis Sci 1997; 38: 676–689, [PUBMED], [INFOTRIEVE], [CSA]
  • Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sawada T, Tsuji K, Tara M, Igata A. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988; 23(Suppl)S143–S150, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I/II and associated diseases. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Suppl 1)S119–S123, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y, Tara M, Nomura K, Utsunomiya A, Hanada S, Tajima K, Sonoda S. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 2001; 17: 1047–1061, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Katahira Y, Yashiki S, Fujiyoshi T, Nomura K, Tara M, Mori M, Setoyama M, Kanzaki T, Shida H, Sonoda S. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Res 1995; 86: 21–27, [PUBMED], [INFOTRIEVE], [CSA]
  • Lou H, Li H C, Kuwayama M, Yashiki S, Fujiyoshi T, Suehara M, Osame M, Yamashita M, Hayami M, Gurtsevich V, Ballas M, Imanishi T, Sonoda S. HLA class I and class II of the Nivkhi, an indigenous population carrying HTLV-I in Sakhalin, Far Eastern Russia. Tissue Antigens 1998; 52: 444–451, [PUBMED], [INFOTRIEVE], [CSA]
  • Ota M, Seki T, Fukushima H, Tsuji K, Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992; 39: 187–202, [PUBMED], [INFOTRIEVE], [CSA]
  • Nomura N, Ota M, Tsuji K, Inoko H. HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1991; 38: 53–59, [PUBMED], [INFOTRIEVE]
  • Bodmer J G, Marsh S G, Albert E D, Bodmer W F, Bontrop R E, Dupont B, Erlich H A, Hansen J A, Mach B, Mayr W R, Parham P, Petersdorf E W, Sasazuki T, Schreuder G M, Strominger J L, Svejgaard A, Terasaki P I. Nomenclature for factors of the HLA system, 1998. Tissue Antigens 1999; 53: 407–446, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Yamano Y, Kitze B, Yashiki S, Usuku K, Fujiyoshi T, Kaminagayoshi T, Unoki K, Izumo S, Osame M, Sonoda S. Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis). J Neuroimmunol. 1997; 76: 50–60, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kitze B, Usuku K, Yamano Y, Yashiki S, Nakamura M, Fujiyoshi T, Izumo S, Osame M, Sonoda S. Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101. Clin Exp Immunol 1998; 111: 278–285, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.